Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–8 of 8 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT07454642
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Cervical Adenocarcinoma, +25 more
- Locations
-
- START Midwest Grand Rapids, Michigan, United States
- NEXT Oncology Irving, Texas, United States
- NEXT Oncology Virginia Fairfax, Virginia, United States
NCT07182149
- Conditions
- Adenocarcinoma Of Esophagus, Adnexal Diseases, Breast Diseases, +39 more
- Locations
-
- Normunity Investigational Site Denver, Colorado, United States
- Normunity Investigational Site New Haven, Connecticut, United States
- Normunity Investigational Site Minneapolis, Minnesota, United States
- Normunity Investigational Site Maumee, Ohio, United States
NCT07334431
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, First-line Therapy, +11 more
- Locations
-
- Henan Cancer Hospital (Affiliated Cancer Hospital of Zhengzhou University) Zhengzhou, Henan, China
Not Yet Recruiting
Evaluation of XYA02 in Patients With Advanced Solid Tumors
NCT07670312
- Conditions
- Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +35 more
- Locations
-
- Chris O'Brien Life House Sydney, New South Wales, Australia
- Westmead Hospital Sydney, New South Wales, Australia
- Monash Medical Centre Melbourne, Victoria, Australia
- Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
NCT07493382
- Conditions
- GEJ Adenocarcinoma
- Locations
-
Not specified
Not Yet Recruiting
Fruquintinib Combined With PD-1 Inhibitor as First-line Maintenance Therapy for Advanced Gastric Cancer
NCT06888037
- Conditions
- First-line Therapy, Fruquintinib, GEJ Adenocarcinoma, +3 more
- Locations
-
- Ruijin Hospital Shanghai, Shanghai Municipality, China
Not Yet Recruiting
Fruquintinib Combined With PD-1 Inhibitor and FOLFOX as First-Line Treatment For Advanced Gastric Cancer
NCT06871527
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Fruquintinib, +11 more
- Locations
-
- The Sixth Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
Active, Not Recruiting
Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers
NCT04430738
- Conditions
- Adenocarcinoma, Adenocarcinoma Of Esophagus, Biliary Tract Diseases, +28 more
- Locations
-
- Mayo Clinic Hospital Phoenix, Arizona, United States
- Mayo Clinic Scottsdale, Arizona, United States
- University of Colorado Denver CTO(CTRC) Aurora, Colorado, United States
- University of Colorado Hospital - Anschutz Cancer Pavilion (ACP) Aurora, Colorado, United States